Attention-Enhanced 2D CNN for Multi-Class Alzheimer’s Disease Classification with Grad-CAM Visualization
DOI:
https://doi.org/10.63746/njtd.v23i2.3831Keywords:
Alzheimer’s Disease, Deep Learning, Brain MRI, Attention Mechanism, Medical Image ClassificationAbstract
Early and accurate diagnosis of Alzheimer’s disease remains a critical challenge in clinical neuroscience, particularly during the mild and moderate stages, when timely intervention can still have meaningful impact. In this study, we propose a deep learning framework based on a 2D convolutional neural network (ResNet-18) enhanced with a Convolutional Block Attention Module (CBAM) for multi-class classification of Alzheimer’s disease stages from brain MRI slices. To address the pronounced class imbalance inherent in the dataset, a class-weighted loss function was combined with aggressive online data augmentation during training. The model was evaluated on a large public dataset comprising over 86,000 MRI slices spanning four diagnostic categories: Non-Demented, Very Mild Dementia, Mild Dementia, and Moderate Dementia. Quantitative evaluation demonstrated a slice-level classification accuracy of 93.7%, with robust performance across all classes, including the underrepresented stages. Interpretability was provided through Grad-CAM visualizations, which highlighted anatomically meaningful regions consistent with established Alzheimer’s disease biomarkers. While these results underscore the potential of attention-augmented 2D CNNs for automated staging of Alzheimer’s disease, the framework has only been validated on a single public dataset and has not yet been tested on independent cohorts. Consequently, this study should be considered a proof-of-concept, and further multi-center, out-of-distribution validation is needed before any clinical deployment can be contemplated.
References
Anwal, L., Chandakavate S., Lalitha S. and Thilagasundari M.K. (2021). A Comprehensive Review on Alzheimer’s Disease. World J Pharm Pharm Sci, 10(7), 1170.
Alzheimer’s Association (2023). Alzheimer’s Association 2023 Annual Report. Available online at: https://www.alz.org/getmedia/ddaaece8-bf59-4b9f-a70a-be869549204f/annual-report-2023.pdf. Accessed on June 10, 2025.
Basaia, S., F. Agosta, L. Wagner, E. Canu, G. Magnani, R. Santangelo and M. Filippi. (2019). Automated Classification of Alzheimer's Disease and Mild Cognitive Impairment using a Single MRI and Deep Neural Networks. NeuroImage: Clinical, 21: 101645. https://doi.org/10.1016/j.nicl.2018.101645.
Chaudhary, R. K., U. V. Mateti, P. Khanal, K. B. Rawal, P. Jain; V.S. Patil, ... B.M. Patil. (2024). Alzheimer's Disease: Epidemiology, Neuropathology, and Neurochemistry. In Computational and Experimental Studies in Alzheimer's Disease.1-14. CRC Press
Dang, C., Y. Wang, Q. Li and Y. Lu. (2023). Neuroimaging Modalities in the Detection of Alzheimer's Disease-Associated Biomarkers. Psychoradiology, 3, kkad009.
Davis, M., T. O'Connell, S. Johnson, S. Cline, E. Merikle, F.Martenyi, and K. Simpson. (2018). Estimating Alzheimer's Disease Progression Rates from Normal Cognition through Mild Cognitive Impairment and Stages of Dementia. Current Alzheimer Research, 15(8), 777-788.
Di Meco, A. and Vassar, R. (2021). Early Detection and Personalized Medicine: Future Strategies against Alzheimer's Disease. Progress in Molecular Biology and Translational Science, 177, 157-173.
Ennab, M. M. H. (2025). A Hybrid Convolutional-Fuzzy Model for Interpretable AI in Healthcare: Improving Transparency and Accuracy in Chronic Disease Management (Doctoral Dissertation, Université du Québec à Chicoutimi). Available online at: https://constellation.uqac.ca/id/eprint/10166/. Accessed on July 4, 2025.
Jack, C. R., T.M. Therneau, S.D. Weigand, H.J. Wiste, D.S. Knopman, P. Vemuri, ... Petersen. (2019). Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities using the National Institute on Aging–Alzheimer’s Association research framework. JAMA Neurology, 76(10), 1174-1183.
Jain, R., N. Jain, R. Aggarwal and D.J. Hemanth. (2019). Convolutional Neural Network Based Alzheimer’s Disease Classification from Magnetic Resonance Brain Images. Cognitive Systems Research, 57, 147–159.
Li, C., Jiao, F., Wu, S., Wang, C., Wei, M., Zhang, S., ... and J. Jiang. (2025). Enhancing interpretability of AI with radiomics-based deep neural network: proof of concept in the classification of Parkinsonian syndromes with 18F-FDG PET imaging. European Journal of Nuclear Medicine and Molecular Imaging, 1-18
Li, F., and M. Liu. (2018). Alzheimer’s disease diagnosis based on multiple cluster dense convolutional networks. Computerized Medical Imaging and Graphics, 70, 101–110.
Lin, D. K. F. (2025). Leveraging Machine Learning for Preliminary Early Onset Alzheimer's Disease Classification Using Cost-Effective Data Modalities (Doctoral Dissertation, Swinburne). https://doi.org/10.25916/sut.28630193
Lu, D., K. Popuri, G.W. Ding, R. Balachandar and M.F. Beg. (2018). Multimodal and Deep Neural Network for the early Diagnosis of Alzheimer's Disease Using Structural MR and FDG-PET Images. Scientific Reports, 8, 5697. https://doi.org/10.1038/s41598-018-22871-z
Molinuevo, J. L, C.Valls-Pedret and L. Rami. (2010). From Mild Cognitive Impairment to Prodromal Alzheimer Disease: A Nosological Evolution. European Geriatric Medicine, 1(3), 146-154.
Mravinacová, S., S. Bergström, J. Olofsson, N.G. de San José, S. Anderl-Straub, J. Diehl-Schmid, ... Månberg. (2025). Addressing Inter individual Variability in CSF Levels of Brain Derived Proteins across Neurodegenerative Diseases. Scientific Reports, 15(1), 668.
Nandi, A., N. Counts, S. Chen, B. Seligman, D. Tortorice, D. Vigo and D.E. Bloom. (2022). Global and Regional Projections of the Economic Burden of Alzheimer's Disease and Related Dementias from 2019 to 2050: A Value of Statistical Life Approach. EClinical Medicine, 51.
OASIS Alzheimer's Detection (2023). Large-scale brain MRI dataset for deep neural network analysis. Kaggle. https://www.kaggle.com/datasets/ninadaithal/imagesoasis
Shaikh, M. R., Jeyabose, A., and Arjunan, R. V. (2025). Deep learning for Alzheimer’s disease: advances in classification, segmentation, subtyping, and explainability. BioMedical Engineering OnLine, 24(1), 150.
Spasov, S., L. Passamonti, A. Duggento, P. Liò and N. Toschi. (2019). A Parameter-Efficient Deep Learning Approach to Predict Conversion from Mild Cognitive Impairment to Alzheimer’s Disease. Neuroimage, 189, 276–287. https://doi.org/10.1016/j.neuroimage.2019.01.031.
Tuan, D. A. (2024). Bridging the Gap between Black Box AI and Clinical Practice: Advancing Explainable AI for Trust, Ethics, and Personalized Healthcare Diagnostics. Computer Science and Mathematics. https://doi.org/10.20944/preprints202409.1974.v2.
Xie, L, L.E. Wisse, J. Pluta, R. de-Flores, V. Piskin, J.V. Manjón, H. Wang, S.R. Das, S. Ding, D.A. Wolk and P.A Yushkevich. (2019). Automated Segmentation of Medial Temporal lobe Subregions on in Vivo T1-weighted MRI in Early Stages of Alzheimer's Disease. Human Brain Mapping, 40(12), 3431-3451.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nigerian Journal of Technological Development

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
In accordance with the Copyright Act of 1976, which became effective January 1, 1978, the following statement signed by each author must accompany the manuscript submitted: "I, the undersigned author, transfer all copyright ownership of the manuscript referenced above to the Nigerian Journal of Technological Development, in the event the work is published. I warrant that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been published previously. I have reviewed and approved the submitted version of the manuscript and agree to its publication in the Nigerian Journal of Technological Development." A copyright transfer form can be downloaded from the NJTD Website (http://njtd.com.ng/index.php/njtd). Author(s) will be consulted, whenever possible, regarding republication of material. All authors must have access to the data presented, and the authors and sponsor (if applicable) must agree to share original data with the editor if requested.
